SIGNAL GRIDv0.1

“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z

1 sources1 storiesFirst seen 8/29/2026Score6Mixed Progress
Single Source
CoverageRecencyEngagementVelocityBignessConfidenceClipability
Bigness
6
Coverage
13
Recency
9
Engagement
4
Velocity
0
Confidence
50
Clipability
50
Polarization
0
Claims
2
Contradictions
0
Breakthrough
50

Sentiment Mix

Positive0%
Neutral100%
Negative0%

Expert Signals

TechCrunch - AI

source1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

"We're not doing 30 bets a year": Vijay Pande on betting small after running $4 billion at a16z.

Supported by 1 story

Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.

Supported by 1 story

Related Events

Timeline (1 stories)

Receipts (1)

Bias Snapshot

Center
Left 0%Center 100%Right 0%
Tradetechcrunch.com8/29/2026